XIAOMING JIA to Recurrence
This is a "connection" page, showing publications XIAOMING JIA has written about Recurrence.
Connection Strength
0.115
-
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials. EBioMedicine. 2023 Jul; 93:104662.
Score: 0.039
-
Multi-arm U-Net with dense input and skip connectivity for T2 lesion segmentation in clinical trials of multiple sclerosis. Sci Rep. 2023 03 13; 13(1):4102.
Score: 0.038
-
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proc Natl Acad Sci U S A. 2023 01 17; 120(3):e2207291120.
Score: 0.038